Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...
Research that won the 10th Bioindustry AwardOn July 15, 2026, Sumitomo Pharma Co., Ltd. and RACTHERA Inc. announced that the ...
Not a question of "which is superior," but differences in qualifications, roles, target conditions, insurance systems, and ...
CI is pairing top AI and biotech minds on its board (plus an advisory role for OpenAI's Fidji Simo) as it tests models on a ...
In AD, BioVie has conducted Phase 2 and Phase 3 trials. Preliminary data from these trials suggest improvements in cognition and biomarkers, supporting further trials to evaluate its potential as a ...
Coya Therapeutics hits its 100th ALS trial enrollment and publishes new preclinical data, both pointing to the same ...
A recent study indicates that carbon monoxide might be responsible for lowering the risk of Parkinson's disease, as opposed to nicotine. Researchers discovered a correlation between elevated carbon ...
Discussion of Phase 2 data on bezisterim in Long COVID and Parkinson's with focus on inflammation targets September 23, 2026 11:00 ...
AC Immune maintains a "Buy" rating, driven by positive 100-week safety and immunogenicity data for ACI-7104. Click to read in ...
Menopause increases the risk of UTIs which can lead to sepsis and death in older women. For years, the FDA discouraged the ...
Imprisoned in Russia for nearly 500 days, Wall Street Journal writer Evan Gershkovich never stopped reporting. His remarkably vivid prison memoir offers an unparalleled view of Russia, its people and ...
Cala®, the bioelectronic medicine leader, today announced it has been named to TIME and Statista's World's Top HealthTech Companies 2026 list in the Medical Devices & Wearables Category. Cala TAPS® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results